These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 14987348)
1. Effect of meconium on the surface properties of perflubron. Fuloria M; Wu Y; Brandt ML; Rubin BK Pediatr Crit Care Med; 2004 Mar; 5(2):167-71. PubMed ID: 14987348 [TBL] [Abstract][Full Text] [Related]
2. Surface properties and the meconium aspiration syndrome. Fuhrman BP Pediatr Crit Care Med; 2004 Mar; 5(2):200-1. PubMed ID: 15080112 [No Abstract] [Full Text] [Related]
3. Comparative effects of bronchoalveolar lavage with saline, surfactant, or perfluorocarbon in experimental meconium aspiration syndrome. Rey-Santano C; Mielgo VE; Gastiasoro E; Alvarez-Diaz FJ; Lafuente H; Valls-i-Soler A; Murgia X Pediatr Crit Care Med; 2012 May; 13(3):e187-94. PubMed ID: 22079955 [TBL] [Abstract][Full Text] [Related]
4. Surfactant inhibition in experimental meconium aspiration. Sun B; Curstedt T; Robertson B Acta Paediatr; 1993 Feb; 82(2):182-9. PubMed ID: 8477165 [TBL] [Abstract][Full Text] [Related]
5. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Ochs M; Schüttler M; Stichtenoth G; Herting E Respir Res; 2006 Jun; 7(1):86. PubMed ID: 16756655 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of pulmonary surfactant function by meconium. Moses D; Holm BA; Spitale P; Liu MY; Enhorning G Am J Obstet Gynecol; 1991 Feb; 164(2):477-81. PubMed ID: 1992687 [TBL] [Abstract][Full Text] [Related]
7. Perfluorocarbon priming and surfactant: physiologic and pathologic effects. Mrozek JD; Smith KM; Simonton SC; Bing DR; Meyers PA; Connett JE; Mammel MC Crit Care Med; 1999 Sep; 27(9):1916-22. PubMed ID: 10507618 [TBL] [Abstract][Full Text] [Related]
8. Effect of nitric oxide in meconium aspiration syndrome after treatment with surfactant. Rais-Bahrami K; Rivera O; Seale WR; Short BL Crit Care Med; 1997 Oct; 25(10):1744-7. PubMed ID: 9377892 [TBL] [Abstract][Full Text] [Related]
9. The surface and transport properties of meconium and reconstituted meconium solutions. Rubin BK; Tomkiewicz RP; Patrinos ME; Easa D Pediatr Res; 1996 Dec; 40(6):834-8. PubMed ID: 8947959 [TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study. Schrama AJ; de Beaufort AJ; Sukul YR; Jansen SM; Poorthuis BJ; Berger HM Acta Paediatr; 2001 Apr; 90(4):412-6. PubMed ID: 11332933 [TBL] [Abstract][Full Text] [Related]
12. Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndrome. Hilgendorff A; Doerner M; Rawer D; Leick J; Trotter A; Ebsen M; Ruppert C; Günther A; Gortner L; Reiss I Crit Care Med; 2006 Jan; 34(1):203-10. PubMed ID: 16374175 [TBL] [Abstract][Full Text] [Related]
13. Morphology and function of pulmonary surfactant inhibited by meconium. Bae CW; Takahashi A; Chida S; Sasaki M Pediatr Res; 1998 Aug; 44(2):187-91. PubMed ID: 9702912 [TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of perflubron and surfactant lung lavage on pulmonary gas exchange in a piglet model of meconium aspiration. Schlösser RL; Veldman A; Fischer D; Funk B; Brand J; von Loewenich V Biol Neonate; 2002; 81(2):126-31. PubMed ID: 11844883 [TBL] [Abstract][Full Text] [Related]
15. Surfactant therapy and high-frequency jet ventilation in the management of a piglet model of the meconium aspiration syndrome. Wiswell TE; Peabody SS; Davis JM; Slayter MV; Bent RC; Merritt TA Pediatr Res; 1994 Oct; 36(4):494-500. PubMed ID: 7816525 [TBL] [Abstract][Full Text] [Related]